The latest malaria news, in 60 seconds.

The FDA’s approval of GSK’s new malaria drug Tafenoquine (Krintafel) provokes a mixed response and a research team from the ANU and The University of Queensland make a ‘small fragment of human protein’ that kills the microbial parasite that causes malaria.

Available Platforms

Got a story?

Email our news team at [email protected] with the story details and we will consider featuring it in the next episode.

Listen to more episodes of Malaria Minute

Never Miss An Update

Subscribe to our Mailing List to be the first to know when we release a new episode.

Other Podcast Titles

The Fight Malaria Podcast

Five Minutes

Print Friendly, PDF & Email
Categories: Malaria Minute

Leave a Reply

Your email address will not be published.